Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Everyone seems to be doing a lot of investing except where it counts...hmmm.
Don't be silly.
Why do I need to call them when they already stated in the pr the trial is going forward. Of course there are cautionary statements and disclaimers but let's not worry about that, right? This leadership hasn't done a thing for their shareholders except lose them massive percentages so why would I take their word now?
Show me the cash!...Show me actual enrollment!
SHOW ME OPEN MARKET INSIDER PURCHASES! That'll speak a lot louder than any private phone call. LoL
In their needy condition not allowing conversion is very unlikely, imo. Sweeten the pot at common's expense over and over again.
What is about the higher percentage you don't understand?
I'd want clarification on that $300M AF stat and if it includes fully diluted or just shares outstanding? My hunch is the later.
New financing at what a penny? More massive dilution?
And sorry I'm just not buying the FDA would allow a trial to move forward with just the first payment in place.
And "Leadership" has not bought a thing on the open market even down here at these horrendous levels.
Sorry I'm aggregating you all but these are legitimate concerns to any real investor.
If the property can be developed the local government will step in and assist the developer with the remediation cost since it'll mean income / jobs to the area. But it will take time. Should be happening now.
There more than one kind of scam. There's the most familiar empty product pump and dump play you're probably thinking of, there's the science for sciences sake salary making/ cash transfer play, there's the Slip the IP out the back door play, and there's the stock destroying dilution / insider accumulation play. Probably others too.
Onc has no cash. By your own own explanation it can't just do fine, the data needs to show something really excellent so the company gets bought out in 2019. Then a BP can run with it.
"If NWBO is a scam, his stock value will go to zero along with his credibility and image. "
Not true. His fund holds a basket of stocks. As long as some do well and the fund is green then nobody will care if NWBO goes to zero.
I know you're all ignoring any connections with the SEC still hanging around and Woodford's investment but that's a mistake, imo. It feels like they're both making their presence known to Powers. The irony may be that if Woodford started making positive comments then Powers could dilute him even further with cash raises? In the long run for a ten percent holder what's worse, having your share price shot to hell temporarily or being diluted forever?
Just thinking out loud.
Better pray it's not the dreaded ATM / AMI.
Good points. Bravo!
I called the office when the stock was a dollar. Head was excited then. I won't be calling the office again.
The whole things feels like maybe the vaccine does some good but there's no current means of affordably manufacturing it? Powers has never offered up a commercialization plan.
Maybe but I remain suspicious. I think we all agree the SEC investigation was probably initiated by a call from Woodford? And Woodford's continued silence even as LL, Bîgger&Co. seem to be saying positive things - is something I can't just look past.
True. And might add while personalized it can be stored for all additional treatments. But more to my point, IF Dvax succeeds they'll likely run prostate trials next.
Do you think they ask about the SEC and why they continue to hang around?
Maybe not in weeks but certainly months. Not unblinding just doesn't add up.
Steve King was even worse, imo.
again, it's not about me folks.
If you're genuine shareholders, better get it in gear.
LOL. You guys have all the answers but just choose not to share on this board. Right, got it....lol.
With such high confidence levels then why it sits at a penny plus a half?
Who should I speak with the receptionist? Lol.
Where's the money?
You people are like a broken record. Can't you come up with some dd remotely interesting that we can all discuss?
Hmm yeah, talk to the hand!
Where's Woodford's comments? Can't the guy just say something positive?
Or pumping to exercise and cash out?
How about a commercialization plan with figures?
Another day another tenth of a penny.
Warrants.
The end of anything good.
Man oh man this board is on steroids today!!!
Oh God.
The sad part is Big Pharma get away with it all the time but here AF has NWBO under a microscope.
And the SEC continues to hang around.
Securities and Exchange Commission
As previously reported, the Company has received a number of formal information requests (subpoenas) from the SEC regarding several broad topics that have been previously disclosed, including the Company’s membership on Nasdaq and delisting, related party matters, the Company’s programs, internal controls, the Company’s Special Litigation Committee, disclosures and the publication of interim clinical trial data. Testimony of certain officers and third parties has been taken as well. The Company has been cooperating with the SEC investigation. As hoped, the investigation is winding to a conclusion. After investigation of a broad array of issues over the past two-plus years, the SEC Staff has informed us preliminarily that they have concerns in regard to two issues, relating to the Company’s internal controls over financial reporting and the adequacy of certain disclosures made in the past. We have previously disclosed material weaknesses in our internal controls. As for disclosures, we believe our disclosures complied with applicable law. Despite our belief that the Staff should close the investigation, there can be no assurance that the Staff will not recommend some action involving the Company and/or individuals. Given the stage of the process, the Company is unable to provide a current assessment of the potential outcome or potential liability, if any.
As previously disclosed, in February, March and April of 2018, the Company and its Chief Executive Officer, Linda F. Powers, entered into demand notes for short-term bridge loans of $5.4 million from Ms. Powers to the Company. The notes have remained outstanding to date. On November 11, 2018, the Company and Ms. Powers agreed to extend the notes to a maturity of one year following the respective funding dates. In consideration of the continuing forbearance, the Company will issue warrants representing 50% of the amounts due under the loans from Ms. Powers. The warrants will have the same exercise price and exercise period as the warrants issued to the investors who loaned the Company $5 million.
Between October 2, 2018 and November 1, 2018, approximately $439,000 principal and $17,000 of accrued interest on certain notes were converted into approximately 3.1 million shares of common stock.
China could take some lessons from Powers wall between her and shareholders.
No, then what did he state except for the obvious?
So you think Beth Israel (the Host) is going to pay for it?
LOL. Thanks Ex. I refuse to waste time reading their filings anymore. So was I right that the new deal was actually the old deal?
Oh please! I thought you found something good for a second. This CEO loan is such a small amount and besides all it does is pay off convertibles, interest and fees. No research.